These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30134449)

  • 1. Detecting Anti-IIa and Anti-Xa Direct Oral Anticoagulant (DOAC) Agents in Urine using a DOAC Dipstick.
    Harenberg J; Schreiner R; Hetjens S; Weiss C
    Semin Thromb Hemost; 2019 Apr; 45(3):275-284. PubMed ID: 30134449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants.
    Papageorgiou L; Hetjens S; Fareed J; Auge S; Tredler L; Harenberg J; Weiss C; Elalamy I; Gerotziafas GT
    Clin Appl Thromb Hemost; 2023; 29():10760296231179684. PubMed ID: 37278029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance Characteristics of DOAC Dipstick in Determining Direct Oral Anticoagulants in Urine.
    Harenberg J; Martini A; Du S; Krämer S; Weiss C; Hetjens S
    Clin Appl Thromb Hemost; 2021; 27():1076029621993550. PubMed ID: 33733904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of DOAC Dipstick Test for Detecting Direct Oral Anticoagulants in Urine Compared with a Clinically Relevant Plasma Threshold Concentration.
    Örd L; Marandi T; Märk M; Raidjuk L; Kostjuk J; Banys V; Krause K; Pikta M
    Clin Appl Thromb Hemost; 2022; 28():10760296221084307. PubMed ID: 35249379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixaban.
    Platton S; Hunt C
    Int J Lab Hematol; 2019 Apr; 41(2):227-233. PubMed ID: 30468572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' Plasma Activity of Heparin, low-Molecular-Weight Heparin or no Anticoagulants on Urine Based DOAC Test Strips.
    Harenberg J; Hetjens S; Weiss C
    Clin Appl Thromb Hemost; 2022; 28():10760296221083667. PubMed ID: 35275493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of a Qualitative Point-of-Care Strip Test to Detect DOAC Exposure at the Emergency Department: A Cohort-Type Cross-Sectional Diagnostic Accuracy Study.
    Merrelaar AE; Bögl MS; Buchtele N; Merrelaar M; Herkner H; Schoergenhofer C; Harenberg J; Douxfils J; Siriez R; Jilma B; Spiel AO; Schwameis M
    Thromb Haemost; 2022 Oct; 122(10):1723-1731. PubMed ID: 35785816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples.
    Sevenet PO; Cucini V; Hervé T; Depasse F; Carlo A; Contant G; Mathieu O
    Int J Lab Hematol; 2020 Oct; 42(5):636-642. PubMed ID: 32567799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How and when to measure anticoagulant effects of direct oral anticoagulants? Practical issues.
    Tripodi A; Braham S; Scimeca B; Moia M; Peyvandi F
    Pol Arch Intern Med; 2018 Jun; 128(6):379-385. PubMed ID: 29968697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.
    Harenberg J; Gosselin RC; Cuker A; Becattini C; Pabinger I; Poli S; Weitz J; Ageno W; Bauersachs R; Celap I; Choi P; Douketis J; Douxfils J; Elalamy I; Falanga A; Fareed J; Favaloro EJ; Gerotziafas G; Herkner H; Hetjens S; Heubner L; Klamroth R; Langer F; Lip GYH; Grory BM; Margetić S; Merrelaar A; Pikta M; Renne T; Schulman S; Schwameis M; Strbian D; Tafur A; Vassart J; Violi F; Walenga J; Weiss C
    Thromb Haemost; 2024 Aug; 124(8):770-777. PubMed ID: 38316416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.
    Gosselin R; Grant RP; Adcock DM
    Int J Lab Hematol; 2016 Oct; 38(5):505-13. PubMed ID: 27265752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of a Novel Chromogenic Direct Thrombin Inhibitor Assay: Clinical Experiences for Dabigatran Monitoring.
    Poli S; Härtig F; Spencer C; Ebner M; Birschmann I; Kuhn J; Faix S; Ziemann U; Häring HU; Lehmann R; Peter A; Hörber S
    Thromb Haemost; 2017 Dec; 117(12):2369-2375. PubMed ID: 29212124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges to Laboratory Monitoring of Direct Oral Anticoagulants.
    Qiao J; Tran MH
    Clin Appl Thromb Hemost; 2024; 30():10760296241241524. PubMed ID: 38650302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know.
    Conway SE; Hwang AY; Ponte CD; Gums JG
    Pharmacotherapy; 2017 Feb; 37(2):236-248. PubMed ID: 27983747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation.
    Margetić S; Ćelap I; Huzjan AL; Puretić MB; Goreta SŠ; Glojnarić AČ; Brkljačić DD; Mioč P; Harenberg J; Hetjens S; Weiss C
    Thromb Haemost; 2022 Sep; 122(9):1542-1548. PubMed ID: 35088395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban?
    Yates SG; Smith S; Tharpe W; Shen YM; Sarode R
    Transfus Apher Sci; 2016 Oct; 55(2):212-215. PubMed ID: 27377884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine-based point-of-care testing for factor-Xa-inhibitors in acute ischemic stroke patients: a feasibility study.
    Doeppner TR; Olbricht L; Maxhuni T; Alhaj Omar O; Sachs UJ; Juenemann MB; Huttner HB; Gerner ST
    Front Neurol; 2023; 14():1330421. PubMed ID: 38162451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions.
    Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
    Stroke; 2017 Sep; 48(9):2457-2463. PubMed ID: 28775134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.
    Ebner M; Birschmann I; Peter A; Spencer C; Härtig F; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
    Crit Care; 2017 Feb; 21(1):32. PubMed ID: 28196509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct oral anticoagulant monitoring: what laboratory tests are available to guide us?
    Sarode R
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):194-197. PubMed ID: 31808890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.